FDA approves drugs for cough, dysmenorrhea

02/28/2013 | RTT News

Hawthorn Pharmaceuticals gained federal approval for its VITUZ oral solution to treat cough and upper respiratory allergies in adults. Cypress Pharmaceuticals also received final approval for its mefenamic acid capsules USP, a generic version of Ponstel Capsules, to address mild-to-moderate pain with primary dysmenorrhea. Hawthorn and Cypress were subsidiaries of Pernix Therapeutics Holdings.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI